UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

Simultaneously, AM Best has revised the outlook to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of “aa-” (Superior) for the health and ...

UnitedHealth Group (NYSE: UNH) is one of the biggest health insurers in the U.S. It plays a critical role in the healthcare industry, and for years, it has been a sound stock to invest in. Since ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

UnitedHealth Group shares plunged nearly 13% on Thursday after a Wall Street Journal report that the U.S. Department of Justice had begun a criminal investigation into the company for potential ...

UnitedHealth Group (UNH) offer strong dividend yields & growth potential, despite the stocks being unloved at this time.

The UnitedHealth Group division is taking Johnson & Johnson's Stelara — one of the most popular, best-known and most expensive "biologic" anti-inflammatory drugs — off the standard formulary for many ...

The health care giant has attacked reports that it is under investigation for possible Medicare fraud by the Department of Justice.

The Justice Department is currently investigating the company's handling of its Medicare advantage business practices, according to sources. Supreme Court deals new blow to Donald Trump on ...